AlphaYouKH
Insider selling
Ken Herrmann sold $77K of Aktis Oncology, Inc. (AKTS) stock
Ken Herrmann, Dir of Aktis Oncology, Inc. (AKTS), sold 3,065 shares of AKTS stock worth $77K, per an SEC Form 4 filed Jul 20, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 17, 2026, 3 days before it was made public.
AKTS has moved -13.9% since the trade date, from $24.89 to $21.43 (Sep 21, 2026 close).
- Traded
- Jul 17, 2026
- Disclosed
- Jul 20, 2026
- Filing delay
- 3 days
- Price since
- -13.9%
- Role
- Dir
- Source
- SEC Form 4
More AKTS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.